Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes

  • Priscilla F. McAuliffe,
  • Kurt W. Evans,
  • Argun Akcakanat,
  • Ken Chen,
  • Xiaofeng Zheng,
  • Hao Zhao,
  • Agda Karina Eterovic,
  • Takafumi Sangai,
  • Ashley M. Holder,
  • Chandeshwar Sharma,
  • Huiqin Chen,
  • Kim-Anh Do,
  • Emily Tarco,
  • Mihai Gagea,
  • Katherine A. Naff,
  • Aysegul Sahin,
  • Asha S. Multani,
  • Dalliah M. Black,
  • Elizabeth A. Mittendorf,
  • Isabelle Bedrosian,
  • Gordon B. Mills,
  • Ana Maria Gonzalez-Angulo,
  •  [ ... ],
  • Funda Meric-Bernstam
  • [ view all ]
  • [ view less ]
  • Article
  • Metrics
  • Comments
  • Media Coverage

Table 1 appears incorrectly in the published article. Please see the correct Table 1 and its legend below.

Reference

  1. 1. McAuliffe PF, Evans KW, Akcakanat A, Chen K, Zheng X, Zhao H, et al. (2015) Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS ONE 10(9): e0136851. pmid:26325287